Dallas-based startup Cacti pioneers innovative therapies by combining artificial intelligence and psychedelic-derived medications to treat chronic pain at its psychological roots.
Main Points:
1. Innovative Approach: Cacti leverages AI to develop psychedelic-derived medicines that specifically target nerve pain and emotional triggers.
2. AI-Powered Insights: The company’s algorithms analyze animal behavior to refine treatment development.
3. Holistic Goal: By resetting the brain’s pain response, Cacti aims to revolutionize chronic pain management with more effective and compassionate treatments.
Summary:
Cacti, a biotech startup in Dallas, is addressing the root causes of chronic pain by combining AI technology with psychedelic-derived medications. Partnering with Blackbox Bio, Cacti utilizes advanced algorithms to observe the effects of experimental drugs on lab mice. These insights help refine treatments that address nerve pain directly and the emotional factors behind chronic pain. The ultimate goal is to develop a holistic treatment method that can provide an alternative to traditional opioid-based pain management, creating a pathway for better patient outcomes.
Source: Artificial Intelligence, Psychedelics, and Psychotherapy Working Together to Fight Chronic Pain
Keep up to date on the latest AI news and tools by subscribing to our weekly newsletter, or following up on Twitter and Facebook.
